ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Alcohol found to boost cancer risk by damaging stem cell DNA – BioNews

Continue reading

2018-01-08 Michael Zand NEWS

Beta Blockers May Boost Immunotherapy, Help Melanoma Patients Live Longer – Newswise (press release)

Beta Blockers May Boost Immunotherapy, Help Melanoma Patients Live LongerNewswise (press release)Newswise — A common, inexpensive drug that is used to prevent heart attacks and lower blood pressure may also help melanoma patients live longer. Researche… Continue reading

2018-01-08 Michael Zand NEWS

Beta Blockers May Boost Immunotherapy, Help Melanoma Patients Live Longer – Newswise (press release)

Beta Blockers May Boost Immunotherapy, Help Melanoma Patients Live LongerNewswise (press release)Newswise — A common, inexpensive drug that is used to prevent heart attacks and lower blood pressure may also help melanoma patients live longer. Researche… Continue reading

2018-01-08 Michael Zand NEWS

Gene-Therapy Update: Mixed Results Don’t Dim Hopes – Barron’s


ReliaWire

Alcohol found to boost cancer risk by damaging stem cell DNA
BioNews
Drinking alcohol damages blood stem cells by altering their DNA, raising the risk of developing cancer, scientists have found. A breakdown product of alcohol – acetaldehyde – is responsible for the damage, according to researchers at the MRC Laboratory …
Here’s How Alcohol Can Damage DNA and Increase Cancer RiskLive Science
How Alcohol Mutates Stem Cells And Damages ChromosomesReliaWire
Alcohol Found To Physically Break DNA In Stem Cells, Providing Potential Cause For CancerInfosurhoy
Theafricom –Sin Chew Jit Poh
all 47 news articles »
Continue reading

2018-01-08 Michael Zand NEWS

Gene-Therapy Update: Mixed Results Don’t Dim Hopes – Barron’s


SMA News Today

Gene–Therapy Update: Mixed Results Don’t Dim Hopes
Barron’s
Three companies developing replacement gene–therapy treatments provided updates last week on clinical trials. Investors were happy with the news at Audentes Therapeutics (ticker: BOLD), and disappointed with what they heard from Avexis (AVXS) and …
FDA Lets AveXis Know the Information It Needs to Approve AVXS-101 for SMA Type 1SMA News Today
REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the …GlobeNewswire (press release)

all 5 news articles »

Continue reading

2018-01-08 Michael Zand NEWS

Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at JP Morgan Healthcare … – Nasdaq

Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at JP Morgan Healthcare …NasdaqAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 g… Continue reading

2018-01-08 Michael Zand NEWS

Stem Cells for Knee Problems? US Doctors Investigate – Wall Street Journal


SMA News Today

Gene–Therapy Update: Mixed Results Don’t Dim Hopes
Barron’s
Three companies developing replacement gene–therapy treatments provided updates last week on clinical trials. Investors were happy with the news at Audentes Therapeutics (ticker: BOLD), and disappointed with what they heard from Avexis (AVXS) and …
FDA Lets AveXis Know the Information It Needs to Approve AVXS-101 for SMA Type 1SMA News Today

all 5 news articles »

Continue reading

2018-01-08 Michael Zand NEWS

Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at JP Morgan Healthcare … – GlobeNewswire (press release)

Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at JP Morgan Healthcare …GlobeNewswire (press release)As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the … Continue reading

2018-01-08 Michael Zand NEWS
  • 1
  • …
  • 694
  • 695
  • 696
  • 697
  • 698
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Wall Street Journal

Stem Cells for Knee Problems? US Doctors Investigate
Wall Street Journal
Jason Dragoo’s Stanford University research team gets 100 to 200 inquiries every day from people interested in joining its clinical trial studying the use of stem cells to treat knee injuries. The interest highlights a growing demand for the use of …